Of the 40 patients with ALS, 12 showed evidence of cognitive impairment, including nine who fulfilled requirements for dementia. There have been no significant distinctions between ALS sufferers who had dementia and those who did not with regards to age, sex, education, site of onset, memory loss, emotional balance, severity of the family or disease history. ALS patients and control participants had similar outcomes on cognitive tests, although patients with more severe ALS showed a decline in verbal abilities beyond what would be associated with motor problems affecting speech muscles. In January 2004 for 38 of 40 sufferers with ALS Survival data from public and medical information were available, who lived typically 3.4 years after testing.Related StoriesNew therapy attacks the source of asthma, treats the condition at cellular levelSMU and University of Maryland researchers awarded NIH grant to combat pediatric asthmaDifferent types of asthma respond differently to fresh experimental treatmentA simple-to-make use of airways inflammation test, Aridol is a dry powder administered to sufferers’ lungs via a little hand-held inhaler. Doctors can use the total results of this test to identify airway hyperresponsiveness – – a hallmark of asthma. Medications could be adjusted according to the severity of the condition.